Junlan Yang

2.1k total citations
55 papers, 1.0k citations indexed

About

Junlan Yang is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Junlan Yang has authored 55 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 13 papers in Molecular Biology and 11 papers in Cancer Research. Recurrent topics in Junlan Yang's work include Cancer Treatment and Pharmacology (10 papers), HER2/EGFR in Cancer Research (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Junlan Yang is often cited by papers focused on Cancer Treatment and Pharmacology (10 papers), HER2/EGFR in Cancer Research (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Junlan Yang collaborates with scholars based in China, United States and Netherlands. Junlan Yang's co-authors include Shunchang Jiao, Haiming Yu, Yanyun Zhu, Jiandong Wang, Bo Yang, Wen Si, Yi Hu, Changshi Xiao, Yuanqiao Wen and Chunhui Zhou and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Environmental Pollution.

In The Last Decade

Junlan Yang

53 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junlan Yang China	18	540	275	204	180	162	55	1.0k
Tian Liao China	22	306 0.6×	614 2.2×	211 1.0×	406 2.3×	191 1.2×	71	1.4k
Tian Chen China	16	479 0.9×	661 2.4×	165 0.8×	570 3.2×	154 1.0×	84	1.7k
Hailong Jin China	16	318 0.6×	171 0.6×	207 1.0×	111 0.6×	197 1.2×	47	834
Dongqing Gu China	16	319 0.6×	341 1.2×	38 0.2×	244 1.4×	172 1.1×	43	1.2k
Jinliang Wang China	22	614 1.1×	202 0.7×	133 0.7×	177 1.0×	602 3.7×	71	1.3k
Shengzhe Zhang China	17	208 0.4×	611 2.2×	119 0.6×	176 1.0×	158 1.0×	30	1.1k
Yehui Shi China	15	203 0.4×	183 0.7×	62 0.3×	94 0.5×	76 0.5×	77	581
Jianfei Fu China	18	342 0.6×	311 1.1×	38 0.2×	307 1.7×	112 0.7×	101	995

Countries citing papers authored by Junlan Yang

Since Specialization

Citations

This map shows the geographic impact of Junlan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junlan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junlan Yang more than expected).

Fields of papers citing papers by Junlan Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junlan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junlan Yang. The network helps show where Junlan Yang may publish in the future.

Co-authorship network of co-authors of Junlan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Junlan Yang. A scholar is included among the top collaborators of Junlan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junlan Yang. Junlan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Junlan, et al.. (2025). Rapid urbanization decelerates regional net anthropogenic phosphorus input: Evidence from the Chengdu-Chongqing urban agglomeration in China. Journal of Environmental Management. 374. 124171–124171. 1 indexed citations

Sun, Peng, Qianqian Wu, Xinlu Wang, et al.. (2025). Joint association of low muscle mass and mild anemia with all-cause, cardiovascular and cancer mortality among US middle and older adults. BMC Public Health. 26(1). 241–241.

Ren, Jianwen, et al.. (2025). Comparison of 1064-nm Nd: YAG picosecond laser with fractional micro-lens array and electro-optical synergy for post-acne erythema: a prospective, randomized, split-face trial. Lasers in Medical Science. 40(1). 67–67. 1 indexed citations

Liu, Lu, et al.. (2025). A source-oriented precise risk assessment of trace metal(loid)s in sediments of the Yangtze River Basin. Environmental Pollution. 384. 126896–126896. 2 indexed citations

Yang, Junlan, et al.. (2023). Dynamic characteristics of net anthropogenic phosphorus input to the upper Yangtze River Basin from 1989 to 2019: Focus on the phosphate ore rich area in China. Journal of Environmental Management. 347. 119140–119140. 17 indexed citations

Zhu, Xiaodong, Yu Zhao, Yuqiu Liu, et al.. (2023). Macrophages release IL11-containing filopodial tip vesicles and contribute to renal interstitial inflammation. Cell Communication and Signaling. 21(1). 293–293. 13 indexed citations

Zhong, Yuting, Yanjun Zhang, Liwen Liu, et al.. (2023). Organising pneumonia caused by hormone (tamoxifen) therapy after radiotherapy for breast cancer: a case report and review of the literature. Annals of Translational Medicine. 11(9). 323–323. 2 indexed citations

Wang, Tao, Pin Zhang, Lijun Di, et al.. (2022). Efficacy and safety of inetetamab in combination with chemotherapy as first-line treatment of HER2-positive metastatic breast cancer: a subgroup analysis in the HOPES study. PubMed. 3. 15–15. 13 indexed citations

Tang, Rong, Junlan Yang, Yanmei Yu, & Yuying Fang. (2022). The effects of cognitive behavioral therapy in women with polycystic ovary syndrome: A meta-analysis. Frontiers in Psychology. 13. 796594–796594. 8 indexed citations

10.

Peng, Liang, Demeng Chen, Jing Yang, et al.. (2017). Inhibition of glutathione metabolism attenuates esophageal cancer progression. Experimental & Molecular Medicine. 49(4). e318–e318. 21 indexed citations

11.

Zhang, Pin, Zhongsheng Tong, Fuguo Tian, et al.. (2016). Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients. Journal of Hematology & Oncology. 9(1). 68–68. 19 indexed citations

12.

Peng, Liang, Zhigang Song, Demeng Chen, et al.. (2016). GINS2 regulates matrix metallopeptidase 9 expression and cancer stem cell property in human triple negative Breast cancer. Biomedicine & Pharmacotherapy. 84. 1568–1574. 34 indexed citations

13.

Yang, Junlan, et al.. (2015). [The expression of fibroblast activation protein-α in primary breast cancer is associated with poor prognosis].. PubMed. 31(3). 370–4. 6 indexed citations

14.

Yu, Haiming, Junlan Yang, Ying Li, & Shunchang Jiao. (2015). [The expression of thymic stromal lymphopoietin in primary tumors of breast cancer is associated with prognosis].. PubMed. 31(2). 239–43, 247. 2 indexed citations

15.

Yu, Haiming, Junlan Yang, Shunchang Jiao, et al.. (2015). Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis. Cancer Immunology Immunotherapy. 64(7). 853–860. 86 indexed citations

16.

Xu, Binghe, Zhongzhen Guan, Zhenzhou Shen, et al.. (2014). Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2-positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel alone. Breast Cancer Research. 16(4). 405–405. 23 indexed citations

17.

Zhu, Yanyun, et al.. (2014). Breast carcinoma with choriocarcinomatous features: a case report and review of the literature. World Journal of Surgical Oncology. 12(1). 239–239. 5 indexed citations

18.

Yang, Bo, Junlan Yang, Hui Liu, et al.. (2013). [Clinical paired study of comparing docetaxel plus capecitabine versus docetaxel plus epirubicin as first-line treatment in women with HER-2 negative advanced breast cancer].. PubMed. 93(18). 1397–400. 4 indexed citations

19.

Li, Ying, Mei Liu, Yanjun Zhang, et al.. (2013). Effects of ARHI on breast cancer cell biological behavior regulated by microRNA-221. Tumor Biology. 34(6). 3545–3554. 17 indexed citations

20.

Zhu, Yanyun, et al.. (2013). Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors. World Journal of Surgical Oncology. 11(1). 19–19. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tian Liao Breakdown of academic impact, for papers by Tian Chen Breakdown of academic impact, for papers by Hailong Jin Breakdown of academic impact, for papers by Dongqing Gu Breakdown of academic impact, for papers by Jinliang Wang Breakdown of academic impact, for papers by Shengzhe Zhang Breakdown of academic impact, for papers by Yehui Shi Breakdown of academic impact, for papers by Jianfei Fu